Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Axonal loss in non-optic neuritis eyes of patients with multiple sclerosis linked to delayed visual evoked potential.
Self-reported health promotion and disability progression in multiple sclerosis.
Cavernoma of the conus medullaris mimicking transverse myelitis.
Treatment of primary progressive multiple sclerosis.
Small molecule glutaminase inhibitors block glutamate release from stimulated microglia.
Activation of CD4(+) Foxp3(+) regulatory T cells proceeds normally in the absence of B cells during EAE.
Kinetics of Proinflammatory Monocytes in a Model of Multiple Sclerosis and Its Perturbation by Laquinimod.
Daclizumab for relapsing remitting multiple sclerosis.
Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.
One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study.
Acquired channelopathies as contributors to development and progression of multiple sclerosis.
Simvastatin treatment does not protect retinal ganglion cells from degeneration in a rat model of autoimmune optic neuritis.
Genetic control of nerve conduction velocity may influence multiple sclerosis phenotype.
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia.
Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen.
Monitoring medication adherence in multiple sclerosis using a novel web-based tool: A pilot study.
The myelin oligodendrocyte glycoprotein directly binds nerve growth factor to modulate central axon circuitry.
A Standardized, Evidence-Based Massage Therapy Program for Decentralized Elite Paracyclists: Creating the Model.
The radiologically isolated syndrome.
Association Between the Neurogenic Bladder Symptom Score and Urodynamic Examination in Multiple Sclerosis Patients With Lower Urinary Tract Dysfunction.
Neuroscience. To learn is to myelinate.
Multiple sclerosis, blood flow, and CSF circulation.
Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern Europeans.
Myelin oligodendrocyte glycoprotein induces aquaporin-4 autoantibodies in mouse experimental autoimmune encephalomyelitis.
Acute transverse myelitis after thoracic epidural anesthesia and analgesia: Should anesthesia and analgesia be blamed?
Pages
« first
‹ previous
…
262
263
264
265
266
267
268
269
270
…
next ›
last »